Novartis AG Share Price

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 10:14:25 14/06/2024 pm IST 5-day change 1st Jan Change
95.01 CHF +0.80% Intraday chart for Novartis AG +0.06% +11.95%

Financials

Sales 2024 * 49.13B 43.7B 4,103B Sales 2025 * 51.26B 45.6B 4,282B Capitalization 218B 194B 18,168B
Net income 2024 * 10.45B 9.29B 873B Net income 2025 * 11.7B 10.4B 977B EV / Sales 2024 * 4.69 x
Net Debt 2024 * 12.71B 11.31B 1,062B Net Debt 2025 * 10.76B 9.57B 899B EV / Sales 2025 * 4.45 x
P/E ratio 2024 *
20.9 x
P/E ratio 2025 *
18.1 x
Employees 76,057
Yield 2024 *
3.43%
Yield 2025 *
3.56%
Free-Float 85.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.80%
1 week+0.06%
Current month+1.97%
1 month+1.83%
3 months+10.94%
6 months+12.05%
Current year+11.95%
More quotes
1 week
93.83
Extreme 93.83
95.26
1 month
90.36
Extreme 90.36
95.41
Current year
83.63
Extreme 83.63
95.41
1 year
83.00
Extreme 83
95.41
3 years
72.84
Extreme 72.84
95.41
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 01/05/01
Director of Finance/CFO 59 01/03/01
Chief Tech/Sci/R&D Officer 62 16/22/16
Members of the board TitleAgeSince
Director/Board Member 62 01/13/01
Director/Board Member 65 28/20/28
Chairman 68 01/13/01
More insiders
Date Price Change Volume
14/24/14 95.01 +0.80% 3,143,025
13/24/13 94.26 -0.42% 2,569,845
12/24/12 94.66 +0.62% 2,660,983
11/24/11 94.08 -0.23% 2,223,841
10/24/10 94.3 -0.68% 2,137,436

Delayed Quote Swiss Exchange, June 14, 2024 at 10:14 pm IST

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.6 USD
Average target price
110.3 USD
Spread / Average Target
+3.48%
Consensus